Remove Initial Public Offering Remove Negotiation Remove Public Trading
article thumbnail

Why Aren’t More Tire Dealerships Going Public?

Focus Investment Banking

The benefits of going public are significant. First, there’s the ability to raise substantial capital by issuing shares to the public in an initial public offering (IPO), as well as secondary offerings. Private equity also provides flexibility in terms of timing and structure.

article thumbnail

Investment Banking – Meaning, Functions and More

Razorpay

Investment Banking Services Initial Public Offering (IPO) When a privately-owned business wants to become a publicly traded company, it goes through an IPO , or Initial Public Offering. Investment Banks help businesses with valuations, deal negotiations, and more. How do they do this?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

“To the Moon”: The Rise of the Retail Investor and What this Means for Dealmakers

Deal Law Wire

Public companies involved in or procuring M&A opportunities need to be aware of the potential value and volatility that has emerged due to the rise of retail investors in both negotiating the deal and communicating its details to the public. Private Companies. Conclusion.

Retail 40
article thumbnail

Transfer Traps: Considerations for Dual-Class Companies Contemplating M&A Transactions

Cooley M&A

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. Voting agreements in public M&A transactions. Vote-down termination fee (i.e., a ’naked no-vote fee’).

M&A 59
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Novartis announced plans to spin off its generics and biosimilars division into a publicly traded stand-alone company.

M&A 40
article thumbnail

Cooley’s 2022 Tech M&A Year in Review

Cooley M&A

The rules are expected to increase the frequency of proxy contests (particularly by less-established activists), afford dissidents increased leverage in settlement negotiations, and increase focus on the strength and qualifications of individual directors.

M&A 52